Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
TSMC
TSM
|
$50.1M |
| 2 |
Vipshop
VIPS
|
$37.3M |
| 3 |
Cognizant
CTSH
|
$36.6M |
| 4 |
Aaon
AAON
|
$35.3M |
| 5 |
WEX
WEX
|
$33.3M |
Top Sells
| 1 |
Oracle
ORCL
|
$88.7M |
| 2 |
NetEase
NTES
|
$51.4M |
| 3 |
Equinix
EQIX
|
$49.8M |
| 4 |
Accenture
ACN
|
$43.2M |
| 5 |
Apple
AAPL
|
$39M |
Sector Composition
| 1 | Technology | 28.02% |
| 2 | Communication Services | 13.64% |
| 3 | Healthcare | 11.56% |
| 4 | Financials | 11.1% |
| 5 | Consumer Discretionary | 10.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
MetLife
MET
$52.9B
| $12.9M | 0.1% |
257,850
+82,864
| +47% | +$4.14M |
|
|
ENV
227
DELISTED
ENVESTNET, INC.
ENV
| $12.9M | 0.1% |
318,253
-4,617
| -1% | -$187K |
|
228
Zimmer Biomet
ZBH
$20.9B
| $12.9M | 0.1% |
121,506
-20,863
| -15% | -$2.21M |
|
229
Goldman Sachs
GS
$223B
| $12.6M | 0.1% |
60,408
-200
| -0.3% | -$41.8K |
|
230
Encompass Health
EHC
$12.6B
| $12.5M | 0.1% |
340,122
+49,526
| +17% | +$1.81M |
|
|
HUB.B
231
DELISTED
HUBBELL INC CL-B
HUB.B
| $12.4M | 0.1% |
114,315
+1,200
| +1% | +$130K |
|
232
Chevron
CVX
$310B
| $12.3M | 0.1% |
128,023
-13,836
| -10% | -$1.33M |
|
233
Xylem
XYL
$34.2B
| $12.3M | 0.1% |
332,584
-63,659
| -16% | -$2.36M |
|
234
Quanta Services
PWR
$55.5B
| $12.3M | 0.1% |
426,192
+4,303
| +1% | +$124K |
|
235
Omega Healthcare
OHI
$12.7B
| $12.3M | 0.1% |
357,284
+63,252
| +22% | +$2.17M |
|
236
Bristol-Myers Squibb
BMY
$96B
| $12.3M | 0.1% |
184,432
-7,291
| -4% | -$485K |
|
|
ININ
237
DELISTED
Interactive Intelligence Group, inc.
ININ
| $12.2M | 0.1% |
274,344
-4,291
| -2% | -$191K |
|
238
Factset
FDS
$14B
| $12.2M | 0.1% |
75,038
-1,007
| -1% | -$164K |
|
239
McDonald's
MCD
$224B
| $12.1M | 0.09% |
126,767
-6,447
| -5% | -$613K |
|
|
IPCM
240
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
| $12M | 0.09% |
217,097
-2,810
| -1% | -$156K |
|
|
ABCO
241
DELISTED
Advisory Board Co/The
ABCO
| $11.5M | 0.09% |
210,999
-3,069
| -1% | -$168K |
|
242
ASML
ASML
$307B
| $11.5M | 0.09% |
110,750
| – | – |
|
|
LEJU
243
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
| $11.5M | 0.09% |
137,552
+50,100
| +57% | +$4.19M |
|
244
RTX Corp
RTX
$211B
| $11.5M | 0.09% |
164,371
-23,738
| -13% | -$1.66M |
|
|
CTLT
245
DELISTED
CATALENT, INC.
CTLT
| $11.5M | 0.09% |
390,775
+150,775
| +63% | +$4.42M |
|
|
EJ
246
DELISTED
E HOUSE (CHINA) HOLDINGS LIMITED
EJ
| $11.3M | 0.09% |
1,675,110
+690,000
| +70% | +$4.64M |
|
247
Protolabs
PRLB
$1.19B
| $11.3M | 0.09% |
166,830
+44,139
| +36% | +$2.98M |
|
248
US Bancorp
USB
$75.9B
| $11.1M | 0.09% |
256,586
-11,983
| -4% | -$520K |
|
249
PNC Financial Services
PNC
$80.5B
| $11.1M | 0.09% |
116,098
-23,331
| -17% | -$2.23M |
|
250
Canadian Pacific Kansas City
CP
$70.3B
| $10.8M | 0.09% |
337,810
-274,415
| -45% | -$8.79M |
|